Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

SciClone Pharmaceuticals Inc (NASDAQ:SCLN)

10.20
Delayed Data
As of Dec 09
 -0.10 / -0.97%
Today’s Change
7.37
Today|||52-Week Range
15.03
+10.87%
Year-to-Date
No recent news for SciClone Pharmaceuticals Inc.

Today’s Trading

Previous close10.30
Today’s open10.30
Day’s range10.10 - 10.55
Volume543,714
Average volume (3 months)417,869
Market cap$525.9M
Dividend yield--
Data as of 4:00pm ET, 12/09/2016

Growth & Valuation

Earnings growth (last year)+16.67%
Earnings growth (this year)+14.29%
Earnings growth (next 5 years)+14.70%
Revenue growth (last year)+16.67%
P/E ratio14.6
Price/Sales3.05
Price/Book2.84

Competitors

 Today’s
change
Today’s
% change
OTICOtonomy Inc+0.75+4.31%
INOInovio Pharmaceutica...+0.01+0.14%
RVNCRevance Therapeutics...+0.20+1.16%
LOXOLoxo Oncology Inc+0.26+0.99%
Data as of 4:00pm ET, 12/09/2016

Financials

Next reporting dateMarch 15, 2017
EPS forecast (this quarter)$0.15
Annual revenue (last year)$157.3M
Annual profit (last year)$29.5M
Net profit margin18.74%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Friedhelm Blobel
Chief Financial Officer, Secretary &
SVP-Finance
Wai-Shun Wilson Cheung
Corporate headquarters
Foster City, California

Forecasts


Search for Jobs